“Likely” Merck Consumer Health Sale Could Bring $8 Billion – Analysts
This article was originally published in The Pink Sheet Daily
Executive Summary
Merck executives shift their position about the potential divestiture of the company’s non-pharma assets, including the consumer health business. J.P. Morgan analysts expect a sale of the consumer unit and say Merck’s brands, including Claritin and Coppertone, could grow globally with a new owner.